{"name":"Endo Pharmaceuticals","slug":"endo-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"testosterone gel 2%","genericName":"testosterone gel 2%","slug":"testosterone-gel-2","indication":"Other","status":"marketed"},{"name":"Fortesta","genericName":"Fortesta","slug":"fortesta","indication":"Other","status":"marketed"},{"name":"Lidoderm","genericName":"Lidoderm","slug":"lidoderm","indication":"Other","status":"marketed"},{"name":"Testim","genericName":"Testim","slug":"testim","indication":"Other","status":"marketed"},{"name":"EN3342","genericName":"EN3342","slug":"en3342","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"testosterone gel 2%","genericName":"testosterone gel 2%","slug":"testosterone-gel-2","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Fortesta","genericName":"Fortesta","slug":"fortesta","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Lidoderm","genericName":"Lidoderm","slug":"lidoderm","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Testim","genericName":"Testim","slug":"testim","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"EN3342","genericName":"EN3342","slug":"en3342","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNT05rLVltSGItU3FXekE2bEZ4SjNtMnRUdVZ2bTRDaW9vTGZXcEhUZlduWWxOeDlKV3IyQjNYMFc2eE9xSURTbDhWQTBOckhzOUN4bWlkY3gybzZReFB2LXFTYWdzUlZJZlpJUm1YeWc3dU5NWnZwRXN4RXBWTWZFNkNYdVlseW01a3ZTV245OU1jMzhrY3NkWkktQm9RQW9IeWo0dk16amsxNGNfYTlVSTY5eHNRM3ZfaUUtSg?oc=5","date":"2025-11-11","type":"deal","source":"Fierce Pharma","summary":"With merger in the books, Mallinckrodt and Endo rebrand as Keenova and spin off Par Health - Fierce Pharma","headline":"With merger in the books, Mallinckrodt and Endo rebrand as Keenova and spin off Par Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPTS13Vlc0bHVWMzRhOHg2dk5iRHV2NE1SczhoOWZmODI1b1VwVXBXU0pVQzhuLVE4MElRLTBra2diTmdIT282amFNQlN2RXRySXNhSGdvdGpnVGdzTjI0a1lWckJHSTJ0Y2U4SkYwUTJCSFByNTdhSEJTNHFpek1sMXZSNldRR2lhejZkYy1LTTJfZnRRN3RPOGpoOGR0VUNWek1uMkRvc1ZwQUJqNFE1bmMtTHFNWnFhd3hfQ2pWSXFpaUJtODhQRXlYMjVrdVRKd08w?oc=5","date":"2025-10-15","type":"pipeline","source":"nypost.com","summary":"Mikie Sherrill took more than $25K from pharma giants accused of fueling opioid crisis, records show - nypost.com","headline":"Mikie Sherrill took more than $25K from pharma giants accused of fueling opioid crisis, records show","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNYkk5RmE2Tm5JbmV4ekNlaThGMVJFbzZFTDJ4M2l5THZ1NDExRkFLUzNNT2tzTmk3NjJBVkNhV2tZOHI2TFhlMWpsM1pCdDJrQUtDQkpOYmxfR1UzeE40R2g4ZHotamEwZlhXN3ljQkhnWDEyWG5KMEpnWVBNZzZfV2p2VjE3Q2FrWEZFSXg2NHJJanRSa3ZvcXM1cWlfV1VZd3M4ZHZrWVdIQVM5cURaNWVqMGJOZG8yRTNiVUln?oc=5","date":"2025-06-17","type":"pipeline","source":"prnewswire.com","summary":"Endo Completes International Pharmaceuticals Business Divestiture - prnewswire.com","headline":"Endo Completes International Pharmaceuticals Business Divestiture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNMVhyZEtaTmlTV3ViX3EyeF9sQ2h2bWtJbUJsMUtUSjZxMVNYcjF2d0pBMFY5RU5oLV9ic2pnRHNPN25taG5CX0dHWDB1MkhwUkhLSGg5OEIxdkNfbXNKRlVRdTRqZVJ3aVFWVml0ZFB4cnBmQzBfUXJmRUhhdmEzR0NmdnY1WWJ3MEQ2dkJURXUwaEhMaVNLZGZR?oc=5","date":"2025-05-27","type":"pipeline","source":"Fierce Pharma","summary":"Indivior nabs Sanofi, Endo alum as chief commercial officer - Fierce Pharma","headline":"Indivior nabs Sanofi, Endo alum as chief commercial officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE85TS1YNGtxWEh5VEhicnBLb21NTG5lbzlOYzVNcEdpdEhRdTJPTngyR1lFTVNmQk1kcTJZT3U4X3BlTFN6WC1kMzU2ZnlIUEtweVpnYWZmb1FZYkk1QjhJejh5VXZJcGJhcVE?oc=5","date":"2025-04-24","type":"regulatory","source":"VISTA.Today","summary":"Malvern-Based Endo Approves $3.5M in Retention Bonuses for Executives Ahead of Merger - VISTA.Today","headline":"Malvern-Based Endo Approves $3.5M in Retention Bonuses for Executives Ahead of Merger","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNcThzZWp3ekJLOUJVcF9wUEsySEM1UERDVE05ZnBCdmdjZFFBckdiWndmdDdnZDJVVER4Sl9XWWNtTGp3M041TWJlLXZlU2d2OXRFUlBRYnhKMUNoS2lqRlN5ODdKZ2w4YlViQ3R2U3NVTll6QTRpTmVIbG5xbjBsRFctVThHazU1enE5RzhZcnIwOUpxNGtZ?oc=5","date":"2025-03-13","type":"deal","source":"Pharmaceutical Technology","summary":"Mallinckrodt and Endo sign $6.7bn merger deal - Pharmaceutical Technology","headline":"Mallinckrodt and Endo sign $6.7bn merger deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE80SnF5VDZyVG56bUoxSFBYUnZvYWhkZVN5U0o0MU4xMWpCSkI1U3RQUzZSV25lLTJ0M0EzSGZWMWZ5aFhFSGt2WHVuUzAwa20yR3JWWnhrWWxaajRZNG4wZy03SEpZYTJwSGRrVUV1bEdVdXQwSlE2MWhvNDI1VUU?oc=5","date":"2025-03-13","type":"deal","source":"MedCity News","summary":"Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal - MedCity News","headline":"Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNTUdzODhUX29RSnNXT2ROdWpzM2RBcVlQVndwd1lsTlNZeWxTZ1RVQ2d2ZEVucWVFbVNVS2dyd0Z6X3ZqZlh4ZWUtQTJoa18xc2FsVjRvNk9pVWRSZXdkS2xNLXBYSnpYY1ljMW81N1N1V1hldUZKLVFMVTc0R3dISUc5LUNIZ3R3dmVNQ1psZlBuVkwxNjFpRFBqVTlBSUdHNHpiag?oc=5","date":"2025-03-13","type":"deal","source":"BioPharma Dive","summary":"Mallinckrodt, Endo to combine in $7B deal - BioPharma Dive","headline":"Mallinckrodt, Endo to combine in $7B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQRVpsN1p0Q0dKLWYxZS1mNDlndzNYbDUwTGw5V0FLTGRGd0E4VmNFLU1XUllJeUNLNGNmQkpHRXY2Z2xNaXQ5SzUtcHJPWWFDenJNY1k2N0hqaGpJQ1ltS0xzMHJwbGZYbmNlSFJ1OTdKTGY4cVdrbXNudHA5aWY4cEVWZDI1emRyaU9HOQ?oc=5","date":"2025-03-13","type":"pipeline","source":"Contract Pharma","summary":"Mallinckrodt and Endo Agree to Combine - Contract Pharma","headline":"Mallinckrodt and Endo Agree to Combine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5DN2Y3dElzTWEyM2JFV1h0ekdfbjFWd0NQc1VVbmh0VTkxYjJjZURkN252Y0wzT1luYk1YX09sVTlJR1BoenhvZmpQc0NJcnVxVUZkU2VxSnZqOVdhU1pucmg4TjRVajVwWXRvV2ZoOWpBbGNQWWtNaWhYZw?oc=5","date":"2025-03-13","type":"pipeline","source":"The Pharma Letter","summary":"Troubled Mallinckrodt and Endo to merge - The Pharma Letter","headline":"Troubled Mallinckrodt and Endo to merge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9IcGZyT252dDlSak1SQ2pXV2ZDcGFVbkJuUDIwOUFlMzdzUWs4TWl1QkljazNvN3g1UDBSNmlxUF9ZS1FCYUJYWDJ2cG9OMkpMQ0Jj?oc=5","date":"2025-03-11","type":"deal","source":"FirstWord Pharma","summary":"Endo divests international pharma unit in $99M deal - FirstWord Pharma","headline":"Endo divests international pharma unit in $99M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQNkNVMTdjd19RQ0k3emZOOU5YTndkRTFKWVg4VndUT1FrWnZUSGhFc3liTG5vbUJyZUNDOERJYk92ZkM4b2JqNnprNkJDazhCbU55N2tYLVdwVGxKckNDUFBqOHFsUVQtZUh5eHByRkdkellPOUhFbUFyQ0t2ZmFIcHpQd0ZTRkpGdWdFakJCa3FCU0tBZ195ODFlR3EwRXo5NHFqVEhCYW9PMVBwR0hQZg?oc=5","date":"2025-03-11","type":"pipeline","source":"The Business Journals","summary":"Endo to divest international pharma unit for $99M - The Business Journals","headline":"Endo to divest international pharma unit for $99M","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":4,"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}